Seite - 25 - in Advances in Neuroimmunology
Bild der Seite - 25 -
Text der Seite - 25 -
BrainSci. 2016,6, 15
4.Discussion
IL-6 is implicated inthepathogenesisofautoimmunedisorders, suchasMSinhumans[20,21].
Acritical roleof IL-6 in theanimalmodelofMS,EAE,hasbeendemonstratedbyanumberof studies:
systemic IL-6KOmiceareresistant toEAE[9–13], andneutralizationof IL-6withantibodies leads to
areduceddisease [22],bynotwell-definedmechanisms.Moreover, studieshavedemonstratedthat
the transgenicexpressionof IL-6 in theCNSbyviral systemsreducesEAE[23]andthat thesystemic
administrationof IL-6also reduces the clinical symptoms inaviralmodelofEAE[24]. Thus, IL-6
canpotentiate, butalso inhibitEAE, reflecting thecomplexityof its actions. Keyquestions remain,
however, includingthe identityof thekeycell types thatproduceandrespondtoIL-6andwhether the
criticalactionsof IL-6areperipheralorcentral.
Because theproductionof IL-6during thecourseofEAEarises fromdiversecellular sourcesboth
in theperipheryandin theCNS, thespecificcontributionofeachsourceof IL-6 to thedevelopmentof
thediseaseneeds tobeestablished.WehavepreviouslydemonstratedaroleofCNSIL-6 inregulating
EAE, becausemice expressing IL-6 only by astrocytes (GFAP-IL6-IL-6KOmice)were capable of
developingtheatypicalEAEknowntooccur inGFAP-IL6mice [13]. Furthermore, inadoptive transfer
experiments,EAEis lesssevere inIL-6KOmicethaninwild-typemice,whichsuggests that IL-6 locally
mediates thedisease intheCNS[10]. Thus,althoughEAEhasalwaysbeenconsideredadiseasemostly
inducedperipherally, itseemsthatCNSIL-6mayalsoplayanimportantrole. Becauseastrocytic IL-6plays
amajorrole inneuroinflammation[25,26]andbecauseastrocytesarethemostabundantcell intheCNS,
astrocytic IL-6seemedtobeanexcellentcandidatetoexamineasthekeyregulatorofEAEintheCNS.
Wehavepreviouslyshownthatcomparedtofloxedmice,Ast-IL-6KOmiceexhibitanumberof
alteredbehaviorsundernormal (basal) conditions, includingchanges inactivity,anxietyandlearning;
aprosurvival roleof astrocytic IL-6 is alsoapparent [17,18]. Here,wepresent results fromstudies
involvinganeuropathologicalcondition,MOG35–55-inducedEAE. Incontrast toresults insystemic
IL-6KOmice,astrocytic-specific IL-6deficiency isunable toprevent typical signsofEAEinduction
andhasnoprominentneuropathologiceffects.However,astrocyte IL-6KOmicedidshowsignificant
delaysof theonsetof theEAE,at least in femalemice,amelioratingtheclinical signs in theearlystages
ofEAE.
AutoreactiveT-cells can result in inflammatorydemyelinationof theCNS, andknowing that
the frequencyof Tregs inMSpatients is unchanged fromcontrols [27] (although their function is
impaired)couldbeaclue to thedecreaseddemyelinationseenonly inAst-IL-6KOfemales, theonly
groupthatpresentedadecrease inTlymphocyte infiltration. Thus,a lowerEAEscoreatearlystages
couldbeduetoan initial impairedTcell infiltrationof theCNS.Thispossibility is consistentwithour
results showingthatAst-IL-6KOfemale (butnotmale)micehadadecreasednumberof infiltrates
in thespinal cordand lowerscores for clinical signs. However, it is important tonote thatweonly
carriedoutCresylvioletandCD3immunostainingforTcells, sowecannotruleout thatachange in
Tcell subpopulations is responsible for thedifferent clinical signsobserved inAst-IL-6KOfemale
mice. IL-6has amajor role inTh17 cell differentiation fromnaiveCD4+ T-cells (reviewed in [28]),
particularly in theEAEmodel [14,29]. EAE-resistant IL-6KOmice showadeficiency inTh17 cell
infiltrates in theCNS[30].Whenresponsiveness to IL-6 isexperimentallyeliminated inThelpercells,
miceshowresistance toEAEinduction,as the IL-21pathwayis intact,butnotactive in theabsenceof
IL-6signaling [31]. Th17cellsproduce IL-17 (amongothercytokines),whichenhances IL-6production
byastrocytes,which, in turn, induces thedifferentiationofTh17 cells in apositive feed-back loop
betweenIL-17andIL-6viaactivationofNF-κBandSTAT-3[32,33]. This loopmaybecompromised
inourAst-IL-6KOanimals,whereastrocyteproductionof IL-6hasbeeneliminated.However, since
Ast-IL-6KOmiceonlyshowadelay inEAE,butarenotresistant toEAE,wecanspeculate that this
astrocytic loopisnotnecessary for thedevelopmentof thedisease;and/or thatneuronal, endothelial
andmicroglial IL-6could insteadallowthispositive feedbackbetweenIL-17andIL-6. Inorder to test
thesehypotheses, adetailedstudyof theexact lymphocyticpopulationpresent in the infiltrateswould
be important,particularlywith furtherbackcrossingtoC57/Bl6mice.
25
zurück zum
Buch Advances in Neuroimmunology"
Advances in Neuroimmunology
- Titel
- Advances in Neuroimmunology
- Autor
- Donna Gruol
- Herausgeber
- MDPI
- Ort
- Basel
- Datum
- 2017
- Sprache
- englisch
- Lizenz
- CC BY-NC-ND 4.0
- ISBN
- 978-3-03842-571-7
- Abmessungen
- 17.0 x 24.0 cm
- Seiten
- 164
- Schlagwörter
- neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
- Kategorie
- Medizin